VBI Vaccines is a biotechnology company focused on vaccine and immunotherapeutic development. Its public website describes a pipeline designed to support both disease prevention and treatment, with programs that have included hepatitis B and other infectious-disease or immunology-related applications. The company has historically emphasized immune-system-directed platforms for both prophylactic and therapeutic use.